C. Trapnell

发表

Glucuronidation of 3′-Azido-3′-Deoxythymidine (Zidovudine) by Human Liver Microsomes: Relevance to Clinical Pharmacokinetic Interactions with Atovaquone, Fluconazole, Methadone, and Valproic Acid

C. Jamis-Dow, J. Collins, R. Klecker, 1998, Antimicrobial Agents and Chemotherapy.

Clinical pharmacology of thalidomide.

C. Trapnell, 1998, AIDS clinical care.

Effects of a single intracoronary injection of basic fibroblast growth factor in stable angina pectoris.

A. Quyyumi, E. Chew, R. Cannon, 2000, The American journal of cardiology.

The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive

C. Flexner, E. Ette, P. Barditch-Crovo, 1999, Clinical pharmacology and therapeutics.

USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: Disease-specific recommendations

Mary E. Wilson, J. Hughes, J. Phair, 1995 .

Fluconazole and enhanced effect of rifabutin prophylaxis.

P. Narang, J. Bianchine, C. Trapnell, 1994, The New England journal of medicine.

The Effect of Multiple‐Dose, Oral Rifaximin on the Pharmacokinetics of Intravenous and Oral Midazolam in Healthy Volunteers

W. Forbes, H. Pentikis, C. Trapnell, 2007, Pharmacotherapy.

Pharmacokinetics of F105, a human monoclonal antibody, in persons infected with human immunodeficiency virus type 1

S. Hammer, M. Samore, C. Spino, 1996, Clinical pharmacology and therapy.

USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus: Introduction

K. Holmes, K. Freedberg, H. Masur, 1995 .

Lack of beta-oxidation defects in human immunodeficiency virus-positive subjects with and without chronic zidovudine exposure.

M. Wachsman, P. Lietman, C. Trapnell, 1996, Blood.

Phase I study of a human monoclonal antibody directed against the CD4-binding site of HIV type 1 glycoprotein 120.

S. Hammer, M. Samore, L. Cavacini, 1998, AIDS research and human retroviruses.

Absence of Effect of Oral Rifaximin on the Pharmacokinetics of Ethinyl Estradiol/Norgestimate in Healthy Females

W. Forbes, H. Pentikis, C. Trapnell, 2007, The Annals of pharmacotherapy.

The Effect of Isotretinoin on the Pharmacokinetics and Pharmacodynamics of Ethinyl Estradiol and Norethindrone

C. Hendrix, A. Guidos, Leena P Shah, 2004, Clinical pharmacology and therapeutics.

The effect of clarithromycin, fluconazole, and rifabutin on sulfamethoxazole hydroxylamine formation in individuals with human immunodeficiency virus infection (AACTG 283)

J. Unadkat, T. Hooton, J. Slattery, 2004, Clinical pharmacology and therapeutics.

Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group.

J. Fahey, C. Shikuma, T. Hooton, 1999, The Journal of infectious diseases.

Metabolism of rifabutin and its 25-desacetyl metabolite, LM565, by human liver microsomes and recombinant human cytochrome P-450 3A4: relevance to clinical interaction with fluconazole

C. Jamis-Dow, J. Collins, R. Klecker, 1997, Antimicrobial agents and chemotherapy.

Quantitation of vaginally administered nonoxynol-9 in premenopausal women.

F. Witter, P. Stratton, F. Hamzeh, 1997, Contraception.

Aerosolized pentamidine. Approved for HIV-infected individuals at high risk for Pneumocystis carinii pneumonia.

S. Nightingale, F. Young, C. Trapnell, 1989, Archives of internal medicine.

Duration of vaginal retention and potential duration of antiviral activity for five nonoxynol‐9 containing intravaginal contraceptives

F. Witter, L. Rocco, C. Trapnell, 1999, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Thalidomide does not alter the pharmacokinetics of ethinyl estradiol and norethindrone

D. Abernethy, D. Flockhart, J. Collins, 1998, Clinical pharmacology and therapeutics.

Systemic pharmacokinetics of rifaximin (RFX) in subjects with shigellosis

D. N. Taylor, R. Haake, C. Trapnell, 2005 .

The effect of rifaximin on the pharmacokinetics (PK) of single doses of intravenous (IV) and oral (PO) midazolam in healthy volunteers

H. Boxenbaum, H. Kastrissios, C. Trapnell, 2004 .

The effect of rifaximin on the pharmacokinetics of a single dose of ethinyl estradiol and norgestimate in healthy female volunteers

H. Boxenbaum, H. Kastrissios, C. Trapnell, 2004 .

Effect of Food on the Relative Bioavailability of Oral Ganciclovir

D. Jung, S. Follansbee, A. Dorr, 1996, Journal of clinical pharmacology.

Pharmacokinetics and Pharmacodynamics of Thalidomide in HIV Patients Treated for Oral Aphthous Ulcers: ACTG Protocol 251

F. Aweeka, M. Chernoff, J. Jacobson, 2001 .

The effect of clarithromycin, fluconazole, and rifabutin on dapsone hydroxylamine formation in individuals with human immunodeficiency virus infection (AACTG 283)

J. Unadkat, T. Hooton, J. Slattery, 2004, Clinical pharmacology and therapeutics.